FDA expands age indications for GSK's Fluarix Quadrivalent flu shot

Jan 13, 2018 , Drug Store News - Retail
Michael JohnsenWith this approval, providers will be able to use the same dose of Fluarix Quadrivalent (15 ug of hemagglutinin per virus strain in 0.5 mL) to cover all eligible persons from 6 months of age and up.
read more

Read the full story...

Trending healthcare news keywords at this moment

patients women doctors digital study cancer care heart tip risk opioid crisis drug finds high teens fda kids adults